Tag results:

SARS-CoV-2

Generation of Human Tonsil Epithelial Organoids as an Ex Vivo Model for SARS-CoV-2 Infection

[Biomaterials] The basal layer cells of tonsil epithelial cell–derived organoids expressed molecules essential for SARS-CoV-2 entry, such as angiotensin-converting enzyme 2, transmembrane serine protease 2 and furin, being susceptible to the viral infection.

Deficiency of SARS-CoV-2 T-cell Responses after Vaccination in Long-Term Allo-HSCT Survivors Translates into Abated Humoral Immunity

[Blood Advances] Recipients of hematopoietic stem cell transplantation showed weaker immune responses to COVID-19 vaccines than healthy controls

ACE2 Overexpressing Mesenchymal Stem Cells Alleviates COVID-19 Lung Injury by Inhibiting Pyroptosis

[iScience] Compared to using MSCs or rh-ACE2 alone, the administration of ACE2-MSCs much more significantly reduced inflammatory factors and pyroptosis factors and alleviated lung injury in vivo and in vitro, which might have been due to the increased activities of secretory ACE2.

Mesenchymal Stem Cell Treatment for COVID-19

[Ebiomedicine] Scientists summarize the major pathological characteristics of COVID-19 and provide scientific and rational evidence for the safety and possible effectiveness of MSCs in COVID-19 treatment.

Innate Lymphoid Cells and COVID-19 Severity in SARS-CoV-2 Infection

[eLife] An observational study found that the abundance of innate lymphoid cells decreased more than 7-fold over the human lifespan - T cell subsets decreased less than two-fold - and is lower in males than in females.

ACE2-Independent Infection of T Lymphocytes by SARS-CoV-2

[Signal Transduction and Targeted Therapy] Scientists confirmed that SARS-CoV-2 viral antigen could be detected in patient peripheral blood cells or postmortem lung T cells, and the infectious virus could also be detected from viral antigen-positive PBCs.

Popular